Patents by Inventor Nassima MESSAL

Nassima MESSAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF OX1R ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
    Publication number: 20190083508
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases.
    Type: Application
    Filed: November 23, 2015
    Publication date: March 21, 2019
    Inventors: Alain COUVINEAU, Thierry VOISIN, Eric OGIER-DENIS, Nassima MESSAL, Valérie GRATIO, Pascal NICOLE
  • Method of treating an inflammatory bowel disease comprising agonists of orexin-1 receptor
    Patent number: 10172921
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases. The presents methods relates to a method of treating an inflammatory bowel disease in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one OX1R agonist.
    Type: Grant
    Filed: June 23, 2015
    Date of Patent: January 8, 2019
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITÉ PARIS DIDEROT—PARIS 7, ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS
    Inventors: Alain Couvineau, Thierry Voisin, Nassima Messal, Eric Ogier-Denis, Xavier Treton
  • PHARMACEUTICAL COMPOSITIONS COMPRISING AGONISTS OF OREXIN-1 RECEPTOR OX1R FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
    Publication number: 20170202925
    Abstract: The present invention relates to methods and pharmaceutical compositions for the treatment of inflammatory bowel diseases. The presents methods relates to a method of treating an inflammatory bowel disease in a subject in need thereof comprising administering the subject with a therapeutically effective amount of at least one OX1R agonist.
    Type: Application
    Filed: June 23, 2015
    Publication date: July 20, 2017
    Applicants: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS DIDEROT - PARIS 7, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
    Inventors: Alain COUVINEAU, Thierry VOISIN, Nassima MESSAL, Eric OGIER-DENIS, Xavier TRETON